Marketing in a Precision World
of physicians agree science
will produce more
over the next 5 years
Only 35% of physicians agree medications today are designed for the biology of their patients
78% agree their patients will pay more for medications tailored to their biology or needs
of physicians agree pursuing
precision medicine for their
patients is a top priority
67% agree precision medicine will greatly improve outcomes in the next 2 years
Only 41% agree they have enough info to discuss
precision medicine with their patients
58% discussing apps or sensors to monitor health
51% discussing tests to improve decisions about what medications to take
47% discussing home-based biological tests
34% have recommended a
home-based test to patients
Only 11% have discouraged patients from using home-based tests to help them make health decisions
of physicians agree home-based testing provides patients with information about their risks of getting a disease
65% agree it helps them better understand their current health
57% agree it helps them decide what medications to take
WHAT PHYSICIANS WANT FROM PHARMA
44% want complimentary testing
42% want info on HCP sites
40% want info from reps
33% want info from MSLs
We are at a pivotal moment in healthcare history. An unprecedented convergence of medical knowledge, technology and data science is revolutionizing patient care.
…bringing together a unique understanding of human biology with new ways to analyze health data.
…the screening, diagnosis, treatment and even prevention of diseases will more quickly and effectively transform the lives of people everywhere – ensuring the right treatment for the right patient at the right time.
ABOUT THE RESEARCH
The age of precision medicine is upon us and already impacting health delivery and treatment choices. While most of the activity, and discussion, centers around the use of precision medicine and therapies for oncology, the future of precision medicine is bright with the rapid proliferation of home testing and diagnostics to help consumers not only assess their risk for a wide range of conditions – but to also help them better understand what treatment options may work for them. Seeking to answer some of the questions related to the future of precision medicine, the DHC surveyed 105 US physicians (a mix of primary care and specialists) on the SERMO network to ask them about their opinions about their current use, future interest, and the impact of precision medicine on their patients. The above highlights are from that research.
Contact us for additional information or getting involved at DHCPHARMA.ORG